Nov. 16, 2023
The Centers for Medicare and Medicaid Services (CMS) recently updated the FAQ for the use of JW and JZ modifiers. Beginning Oct. 1, CMS required the use of JW and JZ modifiers for all claims for drugs from single-use vials or single-use packages payable separately under Medicare Part B. The JW modifier is used to identify any discarded amounts. The JZ modifier is used to attest that there were no discarded amounts. CMS also posted a (non-exhaustive) list of codes subject to the modifier policy.

The American College of Radiology®(ACR®), the Radiology Business Management Association, RadNet, and RayUS met with CMS in September and advocated for the exclusion of imaging contrast agents and radiopharmaceuticals from the JW/JZ reporting requirement. CMS did however indicate the list likely will be updated semi-annually with newly identified codes.

If you have any questions, contact Christina Berry, ACR Team Lead, Economic Policy.

Related ACR News

  • Update on Radiology-related Bills

    An update on Scope of Practice and Prior Authorization bills that have been considered in states this year.

    Read more
  • Breast, Cervical Cancer Early Detection Bill

    ACR supported legislation introduced in the U.S. Senate to strengthen resources for early cancer detection.

    Read more
  • Legislation to Bolster Physician Workforce

    An ACR supported bill increasing the number of Medicare supported GME slots by 14,000 over seven years was introduced in the U.S. House of Representatives.

    Read more